IN2013MN00513A - - Google Patents

Download PDF

Info

Publication number
IN2013MN00513A
IN2013MN00513A IN513MUN2013A IN2013MN00513A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A IN 513MUN2013 A IN513MUN2013 A IN 513MUN2013A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A
Authority
IN
India
Prior art keywords
monoclonal antibody
antigen
fragment
bonded
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Shuji Sato
Takeshi Goto
Shigeru Goto
Toshiaki Nakano
Naoya Ohmori
Kueichen Chiang
Yayoi Shimada
Kenji Mori
Takamitsu Miyagi
Original Assignee
Josai University Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Josai University Corp filed Critical Josai University Corp
Publication of IN2013MN00513A publication Critical patent/IN2013MN00513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN513MUN2013 2010-08-20 2011-08-19 IN2013MN00513A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010185406 2010-08-20
PCT/JP2011/068793 WO2012023614A1 (ja) 2010-08-20 2011-08-19 免疫抑制活性を有するモノクローナル抗体またはその抗原結合断片

Publications (1)

Publication Number Publication Date
IN2013MN00513A true IN2013MN00513A (es) 2015-06-12

Family

ID=45605266

Family Applications (1)

Application Number Title Priority Date Filing Date
IN513MUN2013 IN2013MN00513A (es) 2010-08-20 2011-08-19

Country Status (9)

Country Link
US (1) US9701739B2 (es)
EP (1) EP2631246B1 (es)
JP (1) JP5960596B2 (es)
KR (1) KR101863978B1 (es)
CN (1) CN103534271B (es)
IN (1) IN2013MN00513A (es)
RU (1) RU2559550C2 (es)
TW (1) TWI449710B (es)
WO (1) WO2012023614A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2559550C2 (ru) 2010-08-20 2015-08-10 Дзесаи Юниверсити Корпорейшн Моноклональное антитело, имеющее иммуносупрессивную активность, или его антигенсвязывающий фрагмент
LT2731677T (lt) 2011-07-11 2018-07-10 Glenmark Pharmaceuticals S.A. Antikūnai, kurie prisiriša prie ox40, ir jų panaudojimas
JP2015117181A (ja) * 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤
CN104994875B (zh) * 2013-02-15 2018-10-09 免疫医疗公司 嵌合和人源化抗组蛋白抗体
JPWO2013125687A1 (ja) * 2013-02-22 2015-07-30 学校法人 城西大学 炎症疾患治療剤
CN105850770A (zh) * 2016-05-16 2016-08-17 贾文龙 一种宠物接便器

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503833A (ja) * 1990-12-17 1994-04-28 ザ ジョンズ ホプキンス ユニバーシティ 制御された化学のオリゴマー形態の抗原での免疫応答抑制
JP2004014950A (ja) 2002-06-10 2004-01-15 Nippon Tungsten Co Ltd Ｐｔｃ特性を有するセラミックス材料
US20040052780A1 (en) 2002-09-05 2004-03-18 Hisamitsu Pharmaceutical Co., Inc. Immunosuppresants
JP2004149507A (ja) * 2002-09-05 2004-05-27 Hisamitsu Pharmaceut Co Inc 免疫抑制剤
JP4855261B2 (ja) 2004-09-03 2012-01-18 アマテラスファーマ株式会社 抗ヒストンｈ１モノクローナル抗体およびこれを産生するハイブリドーマ
WO2009001673A1 (ja) * 2007-06-26 2008-12-31 Josai University Corporation Ａｔｐ含有免疫アジュバント
JPWO2009004900A1 (ja) * 2007-06-29 2010-08-26 学校法人 城西大学 ユビキノン含有免疫アジュバント
US20100324469A1 (en) 2007-10-04 2010-12-23 Josai University Corporation Drug product, a method of administrating a vaccine using the drug product, and an apparatus for iontophoresis
JP2011503012A (ja) 2007-11-06 2011-01-27 オクラホマ・メディカル・リサーチ・ファウンデーション 予後に関するバイオマーカーおよび治療の分子標的としての細胞外ヒストン
RU2559550C2 (ru) 2010-08-20 2015-08-10 Дзесаи Юниверсити Корпорейшн Моноклональное антитело, имеющее иммуносупрессивную активность, или его антигенсвязывающий фрагмент
LT2731677T (lt) * 2011-07-11 2018-07-10 Glenmark Pharmaceuticals S.A. Antikūnai, kurie prisiriša prie ox40, ir jų panaudojimas
JP2015117181A (ja) 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤

Also Published As

Publication number Publication date
US9701739B2 (en) 2017-07-11
EP2631246B1 (en) 2016-07-20
JP5960596B2 (ja) 2016-08-02
JPWO2012023614A1 (ja) 2013-12-12
TWI449710B (zh) 2014-08-21
RU2013112324A (ru) 2014-09-27
RU2559550C2 (ru) 2015-08-10
EP2631246A4 (en) 2014-01-15
KR20130137612A (ko) 2013-12-17
TW201300416A (zh) 2013-01-01
CN103534271A (zh) 2014-01-22
EP2631246A1 (en) 2013-08-28
KR101863978B1 (ko) 2018-06-01
CN103534271B (zh) 2016-06-22
US20140010815A1 (en) 2014-01-09
WO2012023614A1 (ja) 2012-02-23

Similar Documents

Publication Publication Date Title
NZ610267A (en) A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
IN2013MN00513A (es)
WO2013059885A3 (en) Polypeptide constructs and uses thereof
EP2532366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
NZ597692A (en) Anti-IGF antibodies
RU2018132044A (ru) Антитела против тау
NZ607969A (en) Cd33 binding agents
MX351682B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
EP2532365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
NZ703653A (en) Anti-fap antibodies and methods of use
WO2012051498A3 (en) Antibodies that bind amyloid oligomers
NZ713461A (en) Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
MX2010004660A (es) NUEVOS ANTICUERPOS ESPECIFICOS DE LOS PEPTIDOS ß-AMILOIDES Y SUS USOS COMO AGENTES DE DIAGNOSTICO Y DROGAS.
NZ612312A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
WO2010129895A3 (en) Cd133 epitopes
MX341309B (es) Anticuerpos especificos del heterodimero de anti-il-23.
MX2011008759A (es) Medios y metodos para fabricar neurotoxina altamente pura.
WO2012091564A3 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding mhc-mage complex that induces apoptosis
EA201270701A1 (ru) Ингибирующие металлопротеины антитела
NZ607615A (en) Antibodies directed against il-17
MX363443B (es) Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas.
WO2012047732A3 (en) Antibody compositions and methods of use
MY166152A (en) Anti-human xcr1 antibodies
WO2010011952A3 (en) Flip death effector domain derived peptides for inducing autophagy